GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Panagene Co Ltd (XKRX:046210) » Definitions » Other Income (Expense)

HLB Panagene Co (XKRX:046210) Other Income (Expense) : ₩-4,841 Mil (TTM As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is HLB Panagene Co Other Income (Expense)?

HLB Panagene Co's other income expense for the HLB Panagene Co's pretax income for the three months ended in Mar. 2024 was ₩2 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-4,841 Mil.

HLB Panagene Co Other Income (Expense) Historical Data

The historical data trend for HLB Panagene Co's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Panagene Co Other Income (Expense) Chart

HLB Panagene Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,915.74 -436.19 650.67 407.76 -4,640.15

HLB Panagene Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.53 48.43 141.75 -5,032.93 1.88

HLB Panagene Co Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-4,841 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HLB Panagene Co  (XKRX:046210) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

HLB Panagene Co (XKRX:046210) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Panagene Co Ltd (XKRX:046210) » Definitions » Other Income (Expense)
Comparable Companies
XKRX:321550 XKRX:388870 XKRX:314130 XKRX:348150 XKRX:261780 XKRX:078160 XKRX:138610 XKRX:065660 XKRX:214260 XKRX:084990 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
54, Techno 10-ro, Yuseong-gu, Daejeon, KOR, 34027
Website
http://www.panagene.com
HLB Panagene Co Ltd Formerly PANAGENE Inc is a South Korea based company engages in the molecular diagnostics business. It develops, manufactures and sells peptide nucleic acid (PNA) genetic diagnostic chips.

HLB Panagene Co (XKRX:046210) Headlines

No Headlines